Structure-based deep learning for binding site detection in nucleic acid macromolecules
Structure-based drug design (SBDD) targeting nucleic acid macromolecules, particularly RNA, is a gaining momentum research direction that already resulted in several FDA-Approved compounds. Similar to proteins, one of the critical components in SBDD for RNA is the correct identification of the bindi...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Oxford University Press
2021
|
| Subjects: | |
| Online Access: | View Fulltext in Publisher |